BioSpace News Archive

Longboard Pharmaceuticals, Inc. announced that members of its senior leadership team will present at the H.C. Wainwright BioConnect Virtual Conference.

ABVC BioPharma, Inc. today announced two clinical sites in Thailand have been selected to participate in the Phase II clinical study of Vitargus®, the first bio-degradable vitreous substitute intended to facilitate retina re-attachment surgery.

SELLAS Life Sciences Group, Inc. announced that John T. Burns has been promoted within the Company to Senior Vice President, Finance, and Chief Accounting Officer.

BIOLASE, Inc., the global leader in dental lasers, announced it will participate in the H.C. Wainwright BIOCONNECT Virtual Investor Conference being held on January 10-13, 2022.

Cryoport, Inc. today announced that Jerrell Shelton will be presenting at the J.P. Morgan 40th Annual Healthcare conference taking place virtually from January 10 - 13, 2022.

Bone Biologics Corporation announced that Jeffrey Frelick, the Company’s president and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 – 13, 2022.

Escient Pharmaceuticals today announced the appointment of Joshua Grass, MBA as Chief Executive Officer effective immediately.

Aeterna Zentaris Inc. announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna Zentaris, will present at the virtual H.C. Wainwright BioConnect Conference taking place January 10-13, 2022.

Laborie Medical Technologies Inc. (Laborie), a leading diagnostic and therapeutic medical technology company, announced that it has acquired a perpetual, exclusive license to the Optilume® Urethral Drug Coated Balloon (DCB), following approval from the U.S. Food and Drug Administration (FDA) in early December.

DiaMedica Therapeutics Inc. announced today the appointment of Kirsten Gruis, M.D. as Chief Medical Officer.